Physician profile
Hernando E Chong
NPI 1386613586
$9,242.28
in general payments reported to CMS, 2019-2025
41 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 90% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,840 · 2020: $449 · 2021: $1,178 · 2022: $1,475 · 2023: $1,193 · 2024: $1,630 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,301.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,655.09 | 2019-2025 | Repatha, Repatha, Otezla |
| Novo Nordisk INC | $1,446.69 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $777.93 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $727.59 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $565.17 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $561.02 | 2021-2025 | Ubrelvy, Synthroid, Qulipta |
| Abbott Laboratories | $475.83 | 2019-2025 | Freestyle Libre 3 |
| Pfizer INC. | $336.62 | 2019-2025 | |
| Exact Sciences Corporation | $313.30 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.23 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $216.74 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $177.31 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $172.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $159.83 | 2019-2024 | Spravato, Xarelto |
| Boston Scientific Corporation | $149.34 | 2025 | Watchman Flx |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hernando Chong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.